306 related articles for article (PubMed ID: 31011885)
1. Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.
Melnikov M; Rogovskii V; Boykо A; Pashenkov M
J Neuroimmune Pharmacol; 2020 Mar; 15(1):37-47. PubMed ID: 31011885
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
Melnikov M; Pashenkov M; Boyko A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070011
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.
Prado C; Gaiazzi M; González H; Ugalde V; Figueroa A; Osorio-Barrios FJ; López E; Lladser A; Rasini E; Marino F; Zaffaroni M; Cosentino M; Pacheco R
Front Immunol; 2018; 9():571. PubMed ID: 29619030
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Dopaminergic System in Autoimmunity.
Vidal PM; Pacheco R
J Neuroimmune Pharmacol; 2020 Mar; 15(1):57-73. PubMed ID: 30661214
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
6. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
[TBL] [Abstract][Full Text] [Related]
7. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
8. [The prospect of dopaminergic therapy in multiple sclerosis].
Melnikov MV; Pashenkov MV; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):67-70. PubMed ID: 33728853
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
[TBL] [Abstract][Full Text] [Related]
11. Dopamine, T cells and multiple sclerosis (MS).
Levite M; Marino F; Cosentino M
J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756
[TBL] [Abstract][Full Text] [Related]
12. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
13. Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Wang Y; Cao L; Xu LM; Cao FF; Peng B; Zhang X; Shen YF; Uzan G; Zhang DH
J Neuroimmune Pharmacol; 2015 Sep; 10(3):506-16. PubMed ID: 25773257
[TBL] [Abstract][Full Text] [Related]
14. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
Wang J; Zhao C; Kong P; Bian G; Sun Z; Sun Y; Guo L; Li B
J Neuroimmunol; 2016 Oct; 299():45-52. PubMed ID: 27725120
[TBL] [Abstract][Full Text] [Related]
16. Quercetin regulates dendritic cell activation by targeting STAT4 in the treatment of experimental autoimmune encephalomyelitis.
Zhou F; Guo YX; Gao R; Ji XY; Tang YX; Wang LB; Zhang Y; Li X
Toxicol Appl Pharmacol; 2024 Jul; 488():116980. PubMed ID: 38823456
[TBL] [Abstract][Full Text] [Related]
17. Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment.
Peón AN; Ledesma-Soto Y; Olguín JE; Bautista-Donis M; Sciutto E; Terrazas LI
Mediators Inflamm; 2017; 2017():8494572. PubMed ID: 28744067
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic Pathways in Obesity-Associated Inflammation.
Leite F; Ribeiro L
J Neuroimmune Pharmacol; 2020 Mar; 15(1):93-113. PubMed ID: 31317376
[TBL] [Abstract][Full Text] [Related]
19. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
